2025 annual financial data
UroGen Pharma 2025 Operating margin
Direct answer
Operating margin was -113.73%.
Operating income was -124,863,000 USD and net income was -153,494,000 USD.
Operating cash flow was -162,444,000 USD.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 109,788,000 USD
- Operating income
- -124,863,000 USD
- Net income
- -153,494,000 USD
- Operating cash flow
- -162,444,000 USD